Inventor · disambiguated record
Sekhar S. Surapaneni
Also filed as: SURAPANENI SEKHAR · SURAPANENI SEKHAR S
9 granted patents·2 pending applications·27 citations·filing 2010–2021
83Inventor score
Top patents by PatentIndex Score
11 records- 0190US11230551B2Deuterated analogs of MK2 inhibitors and uses thereofCELGENE CAR LLC·Filed 2018·Granted Jan 25, 2022·5 cites·13 claims
- 0290US9415049B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Aug 16, 2016·12 cites·27 claims
- 0386US11124525B2Heteroaryl compounds useful as MK2 inhibitorsCELGENE CAR LLC·Filed 2018·Granted Sep 21, 2021·5 cites·17 claims
- 0477US9126950B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2013·Granted Sep 8, 2015·4 cites·24 claims
- 0572US11760763B2Heteroaryl compounds useful as MK2 inhibitorsCELGENE CAR LLC·Filed 2021·Granted Sep 19, 2023·0 cites·11 claims
- 0667US9023886B2Nanosuspension of a poorly soluble drug via microfluidization processCHEN MING J·Filed 2010·Granted May 5, 2015·1 cites·10 claims
- 0751US2017095475A1Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2016·Application pending·0 cites
- 0846US9616019B2Nanosuspension of a poorly soluble drug via microfluidization processCELGENE CORP·Filed 2015·Granted Apr 11, 2017·0 cites·10 claims
- 0945US9757355B2Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amideCHEN MING J·Filed 2012·Granted Sep 12, 2017·0 cites·5 claims
- 1042US9549927B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Granted Jan 24, 2017·0 cites·25 claims
- 1131US2016159774A1Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →